Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers
2020 · Cancer Research · 304 citations
https://doi.org/10.1158/0008-5472.can-19-1363
M
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
233
Papers
11.6K
Citations
43
h-index
62
i10-index
Ming Yi is an academic researcher from China University of Political Science and Law. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Prostate Cancer Treatment and Research & MicroRNA in disease regulation. The author has an h-index of 43, co-authored 199 publications.
ORCID: 0000-0001-9098-1364Papers by this author
worksssGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications
2020 · Scientific Reports · 251 citations
https://doi.org/10.1038/s41598-020-66986-8
High recombination rates and hotspots in a Plasmodium falciparum genetic cross
2011 · Genome biology · 123 citations
https://doi.org/10.1186/gb-2011-12-4-r33
The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma
2015 · Molecular Therapy · 78 citations
https://doi.org/10.1038/mt.2015.72
Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage
2011 · Genome biology · 78 citations
https://doi.org/10.1186/gb-2011-12-8-r77
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer
2013 · Molecular Cancer · 64 citations
https://doi.org/10.1186/1476-4598-12-13
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat